Published in Br J Pharmacol on July 01, 1974
Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis. Br J Pharmacol (1979) 1.27
The effects of morphine on the release of noradrenaline from the mouse vas deferens. Br J Pharmacol (1976) 1.27
The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation. Br J Pharmacol (1975) 0.98
Stimulus-secretion coupling processes in brain: analysis of noradrenaline and gamma-aminobutyric acid release. J Physiol (1976) 0.93
Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists. Br J Pharmacol (1988) 0.84
Indomethacin potentiation of the response of the rabbit portal vein to electrical stimulation: effect of stimulus frequency and train length. Br J Pharmacol (1975) 0.75
On the functional coupling of neurotransmitter uptake and release in brain. Br J Pharmacol (1976) 0.75
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
CHOLINERGIC TRANSMISSION AND ACETYLCHOLINE OUTPUT. Can J Biochem Physiol (1963) 2.26
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J Pharmacol Exp Ther (1968) 1.99
Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat. J Physiol (1965) 1.92
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents. Proc Natl Acad Sci U S A (1966) 1.43
A fluorometric assay for subnanogram concentrations of adrenaline and noradrenaline in plasma. Anal Biochem (1970) 1.36
Variations in noradrenaline output with respect to stimulus frequency, train length and origin of the transmitter. Br J Pharmacol (1972) 1.32
An electrophysiological analysis of the uptake of noradrenaline at sympathetic nerve terminals. J Physiol (1973) 1.30
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
The relative role of recapture and of de novo synthesis for the maintenance of neurotransmitter homeostasis in noradrenergic nerves. Acta Physiol Scand (1969) 1.22
Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline. Br J Pharmacol (1973) 1.07
Increased synthesis and release of noradrenaline and dopamine during nerve stimulation. Life Sci (1967) 1.05
The variation of noradrenaline output with frequency of nerve stimulation and the effect of morphine on the cat nictitating membrane and on the guinea-pig myenteric plexus. Br J Pharmacol (1972) 1.03
The recovery of the capacity for uptake-retention of ( 3 H)noradrenaline in rat adrenergic nerves after reserpine. J Pharm Pharmacol (1972) 0.85
Effect of intermittent nerve stimulation on norepinephrine synthesis and mobilization in the perfused cat spleen. J Pharmacol Exp Ther (1970) 0.85
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
Endogenous opioid peptides: multiple agonists and receptors. Nature (1977) 8.21
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA (1992) 5.07
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep (1998) 4.85
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol (1972) 4.11
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
The use of an optical brightener in the study of plant structure. Stain Technol (1975) 3.70
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
Chronic conditions and risk of in-hospital death. Health Serv Res (1994) 3.00
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89
Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ (1997) 2.87
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther (2015) 2.34
Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. Clin Radiol (2011) 2.30
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Errors in using tobacco withdrawal scale. Tob Control (1998) 2.23
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Osteopontin--a molecule for all seasons. QJM (2002) 2.09
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 2.01
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr (2004) 1.97
A prokaryotic phytochrome. Nature (1997) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 1.89
Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci (1975) 1.88
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care (2005) 1.87
Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis (1979) 1.85
Value of routine chest radiography of psychiatric patients. Br Med J (1980) 1.84
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol (1997) 1.82
Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol (1998) 1.79
Incorporation of labelled amino acids into the enkephalins. FEBS Lett (1977) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci (1975) 1.71
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A (1996) 1.66
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol (2003) 1.61
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Characterization of recombinant phytochrome from the cyanobacterium Synechocystis. Proc Natl Acad Sci U S A (1997) 1.60
Intensive care-management at home: an alternative to institutional care? Age Ageing (2001) 1.58
Lead exposure in a firing range. Am J Public Health (1987) 1.58
In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol (1977) 1.56
Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol (1973) 1.56
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technol Assess (2006) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec (2013) 1.51
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med (2001) 1.50
SnR30: a new, essential small nuclear RNA from Saccharomyces cerevisiae. Nucleic Acids Res (1988) 1.48
Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr (1995) 1.47
Corneal astigmatism in preschool Native Americans. J Am Optom Assoc (1997) 1.46
The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend (1995) 1.46
The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45
Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet (1997) 1.45
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
The chemical stain removal properties of 'whitening' toothpaste products: studies in vitro. Br Dent J (2000) 1.43
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol (1997) 1.43
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther (1969) 1.40
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int (2001) 1.40
Fetal neural graft survival. Lancet (1990) 1.40
Comment on Roth appliance. Am J Orthod Dentofacial Orthop (1993) 1.39
Bridging the chasm: incorporating the medically compromised patient into psychiatric practice. J Psychosoc Nurs Ment Health Serv (1997) 1.39
Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol (1999) 1.38
Midazolam infusion in a pediatric intensive care unit. Ann Pharmacother (1993) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Phytochrome Cph1 from the cyanobacterium Synechocystis PCC6803. Purification, assembly, and quaternary structure. Eur J Biochem (2001) 1.36
Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr (2004) 1.36